These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 17043156)

  • 1. Atrial peptides modify the effect of marinobufagenin on sodium pumps: implications for blood pressure control.
    Buckalew VM
    Hypertension; 2006 Dec; 48(6):1029-30. PubMed ID: 17043156
    [No Abstract]   [Full Text] [Related]  

  • 2. Endogenous cardiac glycosides: hormones using the sodium pump as signal transducer.
    Schoner W; Scheiner-Bobis G
    Semin Nephrol; 2005 Sep; 25(5):343-51. PubMed ID: 16139690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ANP differentially modulates marinobufagenin-induced sodium pump inhibition in kidney and aorta.
    Fedorova OV; Agalakova NI; Morrell CH; Lakatta EG; Bagrov AY
    Hypertension; 2006 Dec; 48(6):1160-8. PubMed ID: 17043158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrahippocampal microinjection of an exquisitely low dose of ouabain mimics NaCl loading and stimulates a bufadienolide Na/K-ATPase inhibitor.
    Fedorova OV; Zhuravin IA; Agalakova NI; Yamova LA; Talan MI; Lakatta EG; Bagrov AY
    J Hypertens; 2007 Sep; 25(9):1834-44. PubMed ID: 17762648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardenolides and bufadienolides as hormones: what is missing?
    Lichtstein D; Rosen H; Dvela M
    Am J Physiol Renal Physiol; 2012 Apr; 302(8):F957-8. PubMed ID: 22301627
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of marinobufagenin on the primary reinforcing effect of ethanol].
    Kashkin VA; Patkina NA; Bagrov AIa; Bagrov IaIu; Zvartau EE
    Ross Fiziol Zh Im I M Sechenova; 2001 May; 87(5):665-9. PubMed ID: 11452801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Natraemia, natriuresis, inhibitors of sodium transport and high blood pressure].
    de Wardener H
    Nephrol Ther; 2007 Dec; 3(7):433-6. PubMed ID: 18047997
    [No Abstract]   [Full Text] [Related]  

  • 8. Volume hormones and blood pressure.
    Genest J
    Ann Intern Med; 1983 May; 98(5 Pt 2):744-9. PubMed ID: 6303174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial PKC beta2 and the sensitivity of Na/K-ATPase to marinobufagenin are reduced by cicletanine in Dahl hypertension.
    Fedorova OV; Talan MI; Agalakova NI; Droy-Lefaix MT; Lakatta EG; Bagrov AY
    Hypertension; 2003 Mar; 41(3):505-11. PubMed ID: 12623951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natriuretic effect of bufalin in isolated rat kidneys involves activation of the Na+-K+-ATPase-Src kinase pathway.
    Arnaud-Batista FJ; Costa GT; Oliveira IM; Costa PP; Santos CF; Fonteles MC; Uchôa DE; Silveira ER; Cardi BA; Carvalho KM; Amaral LS; Pôças ES; Quintas LE; Noël F; Nascimento NR
    Am J Physiol Renal Physiol; 2012 Apr; 302(8):F959-66. PubMed ID: 22237798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natriuretic Factors and Hypertension. Proceedings of a satellite symposium to the 14th ISH meeting. Sevilla, Spain, June 19-20, 1992.
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S1-118. PubMed ID: 7508008
    [No Abstract]   [Full Text] [Related]  

  • 12. Franz Volhard Lecture 1996. Sodium transport inhibitors and hypertension.
    de Wardener HE
    J Hypertens Suppl; 1996 Dec; 14(5):S9-18. PubMed ID: 9120690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiotonic steroids: potential endogenous sodium pump ligands with diverse function.
    Dmitrieva RI; Doris PA
    Exp Biol Med (Maywood); 2002 Sep; 227(8):561-9. PubMed ID: 12192097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The evidence for the existence of an endogenous factor with digitalis activity in mammals: a physiological regulator of the sodium pump?].
    Castañeda-Hernández G
    Arch Inst Cardiol Mex; 1991; 61(5):491-500. PubMed ID: 1663331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marinobufagenin and cyclic strain may activate endothelial NADPH oxidase, contributing to the adverse impact of salty diets on vascular and cerebral health.
    McCarty MF
    Med Hypotheses; 2012 Feb; 78(2):191-6. PubMed ID: 21968275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Natriuretic hormones].
    Koĭchev A; Koĭchev K
    Vutr Boles; 1988; 27(1):8-14. PubMed ID: 2457991
    [No Abstract]   [Full Text] [Related]  

  • 17. The natriuretic hormone and essential hypertension.
    de Wardener HE; MacGregor GA
    Lancet; 1982 Jun; 1(8287):1450-4. PubMed ID: 6123731
    [No Abstract]   [Full Text] [Related]  

  • 18. Endogenous marinobufagenin-like immunoreactive substance. A possible endogenous Na, K-ATPase inhibitor with vasoconstrictor activity.
    Bagrov AY; Dmitrieva RI; Fedorova OV; Kazakov GP; Roukoyatkina NI; Shpen VM
    Am J Hypertens; 1996 Oct; 9(10 Pt 1):982-90. PubMed ID: 8896650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of ouabain and marinobufagenin leads to different structural changes in Na,K-ATPase and depends on the enzyme conformation.
    Klimanova EA; Petrushanko IY; Mitkevich VA; Anashkina AA; Orlov SN; Makarov AA; Lopina OD
    FEBS Lett; 2015 Sep; 589(19 Pt B):2668-74. PubMed ID: 26297827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of marinobufagenin on electrophysiological and contractile characteristics of the rat diaphragm].
    Krivoĭ II; Kravtsova VV; Prokof'ev AV; Vashchinkina EV; Kubasov IV; Drabkina TM
    Ross Fiziol Zh Im I M Sechenova; 2006 Dec; 92(12):1463-73. PubMed ID: 17523467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.